Shanta Devarajan is the Senior Director for Development Economics (DEC) at the World Bank.
Previously, he was the Chief Economist of the World Bank’s Middle East and North Africa Region. Since joining the World Bank in 1991, he has been a Principal Economist and Research Manager for Public Economics in the Development Research Group, and the Chief Economist of the Human Development Network, the South Asia Region and Africa Region. He was a director of the World Development Report 2004, Making Services Work for Poor People. Before 1991, he was on the faculty of Harvard University’s John F. Kennedy School of Government. The author or co-author of over 100 publications, Mr. Devarajan’s research covers public economics, trade policy, natural resources and the environment, and general equilibrium modeling of developing countries. Born in Sri Lanka, Mr. Devarajan received his B.A. in mathematics from Princeton University and his Ph.D. in economics from the University of California, Berkeley.
Shanta's latest blog posts can also be found on his blog, Future Development.
- Can Africa's growth be sustained?
- Does the financial crisis signal the end of free markets and a return to state intervention?
- L'autre débat
- Is information the solution?
- Faut-il dévaluer?
- Real-financial sector links
- Financial Market Turmoil and Africa
- The MDGs at Eight
- Child Survival: The Most Elusive MDG
- Is Africa growing too fast?
- To promote exports, look behind the border
- Oh no, not another economist's blog
- Evidence-based debate on education in Pakistan
- Beggar thine own people?
- The Silver Lining
- Beggar thy neighbor?
- India, service delivery and aid: Devesh Kapur responds
- Unnecessary treatment and systems
- Thanks for your comment. Like
- Teachers and learning outcomes
- Teacher resistance and learning goals
- Public v private
- Low teachers' wages
- Lessons from research
- Learning outcomes and de-politicization of education
- International community
- Informal to formal
- Income effects and subsidies
- Growth and climate change
- Execution deficit and cash tranfers
- Equity in drug prices
- Disentangling the multiple factors
- Chronic illness v. communicable diseases